Life sciences property has established itself as a distinct segment within the UK commercial real estate sector, with characteristics that set it apart from traditional asset classes. This article examines the current size of this sector within the broader property market and its growth trajectory.
Investment
Niche sector, strong momentum: life sciences' growing share of the UK commercial property market
Life sciences real estate is a specialised segment expanding at a speed that outpaces most traditional property sectors.
4 min read
Table of Contents
Written by
More from Life Sciences Real Estate
paid
How CROs and CDMOs navigate real estate decisions
Life science contract organisations balance real estate ownership (73 per cent) vs leasing (27 per cent) based on financial, operational, and strategic considerations.
5 min read
paid
Is Life Science REIT nearing its end?
LABS is exploring options including potential sale or wind-down after facing market challenges, with shares trading at a steep discount to NAV.
3 min read
paid
Pharmaceutical companies and real estate: the rent versus buy decision
Pharmaceutical giants are transforming their real estate strategies. Industry leaders are shifting from traditional property ownership to strategic lease-ownership balancing for financial efficiency and flexibility.
5 min read